On the day of closing arguments in a high-profile New York opioid trial, AbbVie has inked a $200 million settlement to put the case to …
This has been a summer of reckoning for many companies that aggressively marketed opioids while downplaying their addictive power. For Mallinckrodt, which filed for bankruptcy …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
